Long‐term safety and efficacy of canagliflozin as add‐on therapy to teneligliptin in Japanese patients with type 2 diabetes
Takashi Kadowaki; Nobuya Inagaki; Kazuoki Kondo; Kenichi Nishimura; Genki Kaneko; Nobuko Maruyama; Nobuhiro Nakanishi; Yumi Watanabe; Maki Gouda; Hiroaki Iijima
Author Information: Department of Diabetes and Metabolic Diseases
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.